Vagisil Anti-itch Medicated Creme Maximum Strength Cream
Product Images NDC 11509-4402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vagisil Anti-itch Medicated Creme Maximum Strength (NDC 11509-4402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Combe Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vagisil®maximum Strengthanti-itch Crèmenet Wt. 1 Oz. (28 G) (Vagisil Anti Itch Medicated Creme 01)

Vagisil®maximum Strengthanti-itch Crèmenet Wt. 1 Oz. (28 G) (Vagisil Anti Itch Medicated Creme 01)
Packaging label for Vagisil Anti-Itch Medicated Creme Maximum Strength, a topical cream containing benzocaine 20% and resorcinol 3% as active ingredients. The label highlights instant long-lasting itch relief, suitability for external vaginal use, and non-greasy absorption. It includes detailed drug facts, directions, warnings, and inactive ingredients, with the manufacturer listed as Combe Incorporated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.